ObsEva to Host Conference Call and Webcast to Discuss First Quarter 2022 Financial Results and Provide Business Update
ObsEva is preparing to host a conference call on May 17, 2022, at 8:00 a.m. ET to discuss its financial results for Q1 2022, concluding March 31. Participants can join the call via telephone or through a live webcast, which will also be archived for 30 days. ObsEva focuses on developing therapies for women's health, with a pipeline targeting uterine fibroids, endometriosis, and preterm labor. The company's stock is traded on NASDAQ under the ticker OBSV.
- Company has a focused development pipeline for women's health issues.
- Plans to provide financial updates and business insights during the conference call.
- None.
GENEVA, Switzerland – May 12, 2022 – ObsEva SA (NASDAQ: OBSV; SIX: OBSN), a biopharmaceutical company developing and commercializing novel therapies for women’s health, today announced that it plans to host a conference call on Tuesday, May 17, 2022, at 8:00 a.m. ET to discuss its financial results for the quarter ended March 31, 2022 and provide a business update.
Individuals may participate via telephone by dialling (877) 300-8521 (domestic) or +1 (412) 317-6026 (international) and using conference ID 10166576. The webcast can be accessed live here and will also be accessible under “Events Calendar” in the investors section of ObsEva’s website. The webcast will be archived on the company’s website for at least 30 days after the conference call.
About ObsEva
ObsEva is a biopharmaceutical company developing and commercializing novel therapies to improve women’s health. Through strategic in-licensing and disciplined drug development, ObsEva has established a late-stage clinical pipeline with development programs focused on new therapies for the treatment of uterine fibroids, endometriosis, and preterm labor. ObsEva is listed on the Nasdaq Global Select Market and is traded under the ticker symbol “OBSV” and on the SIX Swiss Exchange where it is traded under the ticker symbol “OBSN”. For more information, please visit www.ObsEva.com
For further information, please contact:
CEO Office contact
Shauna Dillon
shauna.dillon@obseva.ch
+41 22 552 1550
Investor Contact
Katja Bührer
katja.buhrer@obseva.com
+1 (917) 969-3438
Attachment
FAQ
When is ObsEva's next conference call?
What will ObsEva discuss in its conference call?
How can I participate in ObsEva's conference call?
Where can I find the webcast for ObsEva's conference call?
